Oxigénio Medicinal Portátil Nippon Gases (Oxygen)

Oxygen, the active ingredient in Oxigénio Medicinal Portátil Nippon Gases, is a medical gas presented as a portable delivery system for inhalation use. It provides supplemental oxygen to patients with respiratory insufficiency, hypoxaemia, or those requiring oxygen therapy in acute or chronic settings. GNH USA supplies Oxigénio Medicinal Portátil Nippon Gases as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide.

GNH USA supplies Oxigénio Medicinal Portátil Nippon Gases as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide.

Oxigénio Medicinal Portátil is used to address conditions where oxygen delivery is required to maintain adequate tissue oxygenation.

- Chronic obstructive pulmonary disease (COPD): Improves oxygen saturation and reduces dyspnoea during daily activities. - Acute respiratory failure: Provides immediate supplemental oxygen to stabilize blood oxygen levels. - Post‑operative recovery: Supports oxygenation after surgery to promote healing and reduce hypoxaemia risk. - Home oxygen therapy: Enables long‑term oxygen supplementation for patients with chronic hypoxaemia. - High‑altitude exposure: Prevents hypoxic symptoms for individuals traveling to high elevations.

Oxygen therapy is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Dry or irritated nasal passages: Discomfort or crusting in the nasal mucosa. - Headache: Mild to moderate headache related to changes in oxygen levels. - Fatigue: Transient tiredness after initiating therapy. - Cough: Irritation of the airway leading to a dry cough.

Serious or Rare Side Effects: - Oxygen toxicity: Pulmonary or central nervous system effects from prolonged high‑concentration exposure. - Fire hazard: Increased risk of combustion when used near open flames or sparks. - Barotrauma: Lung injury from excessive airway pressure in pressurised delivery systems. - Hypercapnia: Retention of carbon dioxide in patients with chronic CO₂ retention.

When using portable oxygen devices, follow safety and handling guidelines to ensure effective therapy and minimize risks.

- Patient assessment: Verify the need for supplemental oxygen and appropriate flow rate. - Device maintenance: Inspect tubing, connectors, and regulator for damage before each use. - Fire safety: Keep away from open flames, smoking materials, and hot surfaces. - Monitoring: Regularly check oxygen saturation and adjust flow as prescribed. - Contraindications: Do not use in patients with untreated pneumothorax. - Store at ambient temperature: Keep the cylinder or canister in a cool, dry place, protected from light.

Oxygen therapy may interact with certain medications and clinical conditions.

Major Interactions (Avoid): - Nitrogen dioxide (NO₂) exposure: Increases risk of pulmonary irritation. - Sedatives/analgesics: May exacerbate respiratory depression when combined with high‑flow oxygen.

Moderate Interactions (Monitor Closely): - Chemotherapy agents: Some may increase susceptibility to oxygen‑induced lung injury. - Hyperbaric conditions: Concurrent use with hyperbaric oxygen therapy requires careful monitoring. - Chronic obstructive pulmonary disease (COPD) with CO₂ retention: Requires vigilant observation of CO₂ levels. - Smoking: Elevated fire risk when oxygen is present.